BioSpace News Archive

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced it will present at the Global Chinese Financial Forum (GCFF) Virtual Conference—Diversified Investing Strategies on November 5 at 1:45 p.m. Eastern Time. Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder will present virtually to provide an update on the devel

CohBar, Inc. announced it will host a Key Opinion Leader webinar on the current treatment landscape in idiopathic pulmonary fibrosis, the unmet medical need, and positive findings from preclinical studies of its CB5138 Analogs on Friday, November 6 at 2:00pm ET.

FDA-approved prescription drugs Lysodren® and Metopirone® in the United States

- New executive brings strong legal experience serving as General Counsel for biopharmaceutical companies as Edgewise advances clinical muscular dystrophy program -

Enables compliant, timely surveillance and outcomes research to help get safe and effective therapies to patients faster

Schweiger Dermatology Group announced that it has acquired the Harkaway Center for Dermatology and Aesthetics, with locations in Delran and Northfield, New Jersey.

Epic’s Comprehensive Cancer Profiling™ now includes the broadest ctDNA assay PredicineATLAS™

Financing to build on significant 2020 commercial momentum following the publication of 5-year data demonstrating the long-term clinical benefits of the Intracept Procedure

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today presented initial data from the ongoing long-term, open-label extension study of the investigational medicine CTP-543 in patients with moderate to severe alopecia areata, an autoimmune disorder that results in patchy or complete hair loss. The data from this long-term extension study show that, relative to previous Phase 2 study results of CTP-543, hair regrowth asses

Funding to advance Synaptive’s suite of fully automated cranial and spinal equipment and software designed to optimize personalized patient care